Max Rady College of Medicine
Term: Angiotensin Converting Enzyme Inhibitors (ACEIs)
Glossary Definition
Last Updated: 2008-02-28
Definition:
A therapeutic class of drug commonly used to treat hypertension and other cardiovascular risks. In the Anatomical Therapeutic Chemical (ATC) drug classification, the first four digits of ACEI drugs are C09A and C09B.
Related terms
- Anatomical Therapeutic Chemical (ATC) Drug Classification System
- Angiotensin Converting Enzyme (ACE) Inhibitor Use
- Angiotensin II Receptor Antagonists (A2RAs)
- Angiotensin II Receptor Blockers (ARB)
References
- Morgan SG, Kozyrskyj A, Metge C, Roos NP. Pharmaceuticals: Therapeutic interchange and pricing policies. Winnipeg, MB: Manitoba Centre for Health Policy, 2003. [Report] [Summary] (View)
Term used in
- Katz A, Bogdanovic B, Soodeen R. Physician Integrated Network Baseline Evaluation: Linking Electronic Medical Records and Administrative Data. Winnipeg, MB: Manitoba Centre for Health Policy, 2010. [Report] [Summary] (View)
- Metge C, Kozyrskyj A, Dahl M, Yogendran M, Roos NP. Pharmaceuticals: Focussing on Appropriate Utilization. Winnipeg, MB: Manitoba Centre for Health Policy, 2003. [Report] [Summary] (View)
Request information in an accessible format
If you require access to our resources in a different format, please contact us:
- by phone at 204-789-3819
- by email at info@cpe.umanitoba.ca
We strive to provide accommodations upon request in a reasonable timeframe.
Contact us
Manitoba Centre for Health Policy
Community Health Sciences, Max Rady College of Medicine,
Rady Faculty of Health Sciences,
Room 408-727 McDermot Ave.
University of Manitoba
Winnipeg, MB R3E 3P5 Canada
204-789-3819